When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
The FDA accepts for review Celgene's (NASDAQ:CELG) marketing application seeking approval for luspatercept for beta-thalassemia and myelodysplastic syndromes.
More news on: Celgene Corporation, Acceleron Pharma Inc., Healthcare stocks news,